Brief: Oryzon Genomics Q2 Income From Operations USD -4.344 Million
30/07/2025 13:00
July 30 (Reuters) - Oryzon Genomics SA ORY.MC: ORYZON GENOMICS Q2 OPERATING EXPENSES USD 4.344 MILLION ORYZON GENOMICS Q2 NET INCOME USD -1.721 MILLION ORYZON GENOMICS Q2 INCOME FROM OPERATIONS USD -4.344 MILLION Source text: ID:nGNX3vNPQB Further company coverage: ORY.MC ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28